DSS, Inc. announced the closing of its firm commitment underwritten public offering on February 5, 2026, raising gross proceeds of approximately $1.0 million before fees and expenses. The transaction consisted of 900,000 newly issued shares and included a 15% overallotment option for an additional 135,000 shares granted to Aegis Capital Corp. The offering was conducted under the Company’s shelf registration on Form S-3, declared effective by the SEC in November 2024.

Management intends to deploy the net proceeds toward general corporate purposes, including bolstering working capital across its diversified operations in product packaging, biotechnology, commercial lending, and securities and investment management. By reinforcing liquidity, the Company aims to accelerate growth initiatives within its high-growth subsidiaries and position itself for strategic IPOs or public listings of those businesses over the next 12 to 18 months.

Aegis Capital Corp. served as sole book‐running manager for the offering. Sichenzia Ross Ference Carmel LLP acted as legal counsel to DSS, Inc., while Kaufman & Canoles, P.C. provided counsel to the underwriter. All offering documents, including the final prospectus supplement and base prospectus, will be filed with the U.S. Securities and Exchange Commission and available on the SEC’s website.